Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.67, read 2026-11-05
Ethical passes the values gate
Price280.90 USD
Fair value327.40
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-24Read Distribution319.40-12.1% to today ✓Accumulation gives way to Distribution
2026-10-02Read Accumulation320.39-12.3% to today Markdown gives way to Accumulation
2026-09-21Read Markdown316.98-11.4% to today ✓Accumulation gives way to Markdown after an 11% slide in 4 weeks
2026-08-21Read Accumulation357.62-21.5% to today Markdown gives way to Accumulation after a 12% rise in 7 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Applied Industrial Technologies Inc holds its Distribution at $280.90. Elevated stress, defensive posture warranted, held for 4 days.
As held on the ledger · 2026-11-05
Phase
Distribution · caution
Quantitative state
Elevated stress, defensive posture warranted, held for 4 days
Price at the screen
$280.90
Valuation
24.88 trailing · 21.22 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.86
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
18.02%
Below 33%
Interest-bearing debt is just 18.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
36.47%
Below 49%
Money owed to the company is 36.5% of assets, under the 49% limit.
Pass
Revenue purity
0.39%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Applied Industrial Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when AIT's ethical verdict changes
Today AIT passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 14% discount to our $327.40 fair value, narrow competitive moat, 7.60% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 14.2% discount to the base estimate.
Where our models see it going: fair-value estimate $327.40, with a range of $315.00 to $376.51, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Paying premium for steady factory supplies
Picture the local depot that keeps factory belts turning and pumps running across the Midwest. Applied Industrial Technologies sits in that spot, shifting motion and automation parts with 7% revenue growth, 8% margins and a solid 22% return on equity. Yet the shares trade at 336 dollars against a fair value nearer 276, a clear stretch.
We pass because the 28.5 times forward earnings already prices in better days than the narrow moat and modest growth can deliver. Analyst targets sit higher still, but our valuation leaves no margin of safety and the opportunity rating is none.
The main risks are cyclical demand swings in manufacturing and the narrow competitive edge that could erode if larger rivals tighten grip. Currency and input cost moves add further pressure in this distribution model. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AIT trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-03Distribution$298.50-6.5%Entry 19
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334.
2026-10-27Distribution$319.40+0.0%Entry 18
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$319.40+0.0%Entry 17
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 3% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$319.40+0.0%Entry 16
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$319.40-4.3%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 4.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$333.83+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$333.83+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Accumulation$333.83+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Accumulation$333.83-0.5%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 36%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (5 analysts) rates it buy, with a mean price target of $334.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
